We isolate novel lytic phages from environmental samples, screening for high-potency candidates suitable for therapeutic applications against multi-drug resistant bacteria.
Bacteriophages, the most abundant biological entities on Earth, have evolved sophisticated strategies to ensure their survival and propagation within bacterial hosts. These strategies are broadly classified into two primary life cycles: the lytic cycle and the lysogenic cycle. Understanding these distinct pathways is fundamental to grasping the ecological impact of phages and leveraging them for biotechnological applications. At Creative Biolabs, we provide comprehensive Phage Services to help researchers elucidate these complex mechanisms. Whether exploring the rapid replication of the lytic cycle or the latent potential of prophages, our platform supports advanced phage discovery and engineering.
The choice between these two cycles is not merely a random event but a complex decision-making process influenced by the metabolic state of the host, the multiplicity of infection, and environmental cues. This plasticity allows phages to maximize their fitness, choosing immediate replication when conditions are favorable or dormancy when host resources are scarce.
The lytic cycle of bacteriophage is characterized by the immediate hijacking of the host's cellular machinery to produce new viral progeny, culminating in the destruction (lysis) of the bacterial cell. This process is typical of virulent phages (e.g., T4 phage) but can also be executed by temperate phages under specific conditions.
Fig.1 Schematic of the bacteriophages lytic cycles.
In contrast, the lysogenic cycle allows the phage to coexist with its host. This pathway is unique to temperate phages (e.g., Lambda phage). Instead of killing the host immediately, the phage genome integrates into the bacterial chromosome or exists as a stable plasmid, becoming a prophage.
Fig.2 Schematic of the bacteriophages lysogenic cycles.
Understanding the difference between lytic and lysogenic cycle mechanisms is crucial for applications ranging from phage therapy to synthetic biology. The following table summarizes the key distinctions to compare and contrast the lytic and lysogenic cycles.
| Feature | Lytic Cycle | Lysogenic Cycle |
|---|---|---|
| Fate of Host Bacterium | Lysis and death | Survival (until induction) |
| Phage State | Virulent / Vegetative replication | Temperate / Prophage (latent) |
| Genetic Integration | Rare (host DNA often degraded) | Common (Integration into host genome) |
| Timeline | Immediate (minutes to hours) | Indefinite (can persist for generations) |
| Trigger for Switch | N/A (Obligately lytic phages) | Environmental stress (SOS response) |
The distinction between lytic vs lysogenic pathways dictates the utility of a phage in different fields. In phage therapy, obligately lytic phages are strictly preferred because they ensure the rapid killing of pathogenic bacteria without the risk of horizontal gene transfer or resistance development associated with prophages. Conversely, the lysogenic cycle is a powerful tool in synthetic biology and genetic engineering. The integration mechanisms of lysogenic phages (like the Lambda Red system) are widely used for precise gene editing and the construction of recombinant strains.
Furthermore, the study of the lysogenic pathway has revealed mechanisms of bacterial virulence. Many bacterial toxins (e.g., cholera toxin, diphtheria toxin) are encoded by prophages, transforming a harmless bacterium into a pathogen—a phenomenon known as lysogenic conversion.
Creative Biolabs offers a suite of services designed to leverage the unique properties of both lytic and lysogenic phages for your research.
We isolate novel lytic phages from environmental samples, screening for high-potency candidates suitable for therapeutic applications against multi-drug resistant bacteria.
Comprehensive analysis of phage life cycles, including one-step growth curves, adsorption rates, and host range determination to distinguish virulent from temperate phages.
Manipulation of temperate phages to remove virulence factors, creating stable delivery vectors or improved strains for biotechnological production.
High-titer production and purification of phages at any scale, ensuring the removal of endotoxins and host contaminants for downstream applications.
The rapid expansion of phage genomic data necessitates robust computational tools to distinguish between virulent and temperate phages, a distinction pivotal for the safety of phage therapy. As depicted in Fig.3, the DeepPL framework introduces a novel deep learning approach to address this challenge. The methodology begins with the comprehensive collection of complete phage genomes from public databases, ensuring a diverse representation of both lifecycles. To maintain data integrity, sequences undergo preprocessing where non-standard nucleotides are replaced, and lifecycles are manually verified against existing literature. The framework's architecture relies on the extraction of lysogenic genes, using a sliding window strategy to convert DNA sequences into k-mer sets. These sets are processed by a fine-tuned DNABERT model, which assigns binary classification probabilities to sequence segments. A hierarchical thresholding mechanism is then applied: an initial threshold filters for high-confidence matches between DNA segments and lysogenic markers, while a second, aggregated threshold (0.016) serves as the definitive classifier. Scores falling below this specific cutoff predict a lytic lifestyle, whereas higher scores indicate a lysogenic one. This systematic, data-driven framework significantly enhances the accuracy of lifestyle prediction, facilitating the selection of optimal candidates for antimicrobial applications. This research underscores the importance of genomic analysis in determining the lytic or lysogenic potential of phages, a critical step for therapeutic development.
Fig.3 An overview of DeepPL framework for predicting phage lifecycle, including data collection, feature extraction, and model training.1
Q: What is the main difference between lytic and lysogenic cycle?
Q: Can a lysogenic phage become lytic?
A: Yes, this process is called induction. Under stress conditions such as UV radiation or exposure to certain chemicals (e.g., Mitomycin C), the bacterial SOS response is activated. This triggers the cleavage of the phage repressor protein (like cI), causing the prophage to excise from the host genome and enter the lytic life cycle to produce new virions.
Q: Why are lytic phages preferred for phage therapy?
A: Lytic phages are preferred because they rapidly kill the target bacteria, reducing the bacterial load at the infection site. Unlike temperate phages, they do not integrate into the host genome, minimizing the risk of transferring virulence factors or antibiotic resistance genes (transduction) and ensuring the bacteria are eliminated rather than merely carrying a dormant virus.
Q: What is lysogenic conversion?
A: Lysogenic conversion occurs when a prophage (integrated phage DNA) expresses genes that alter the phenotype of the host bacterium. This often includes virulence factors, such as the production of toxins (e.g., cholera toxin, diphtheria toxin), which can turn a non-pathogenic bacterium into a deadly pathogen.
Q: How do environmental factors influence the switch between cycles?
A: The decision is often based on the nutritional state of the host and the multiplicity of infection (MOI). Generally, when host bacteria are starving or slow-growing, phages tend to enter the lysogenic cycle to wait for better conditions. Conversely, when hosts are abundant and healthy, phages favor the lytic cycle for rapid propagation.
Q: What is the 'Arbitrium' system in phages?
A: The Arbitrium system is a molecular communication mechanism used by some phages to decide between lysis and lysogeny. Phages produce a small peptide during infection. As the concentration of this peptide rises (indicating a high viral load in the population), subsequent infections are biased toward lysogeny to prevent wiping out the entire host population.
Q: Can we detect if a phage is lysogenic in the lab?
A: Yes. Lysogeny can be detected by genomic sequencing (looking for integrase genes or repressor homologs) or by experimental induction. In the lab, treating a bacterial culture with inducing agents like Mitomycin C or UV light and observing a subsequent drop in optical density (lysis) indicates the presence of inducible prophages.
Q: What is superinfection immunity?
A: Superinfection immunity is a phenomenon where a bacterium containing a prophage (lysogen) is immune to infection by the same or closely related phages. The repressor protein produced by the prophage shuts down the lytic genes of any incoming phage DNA, protecting the host and ensuring the resident prophage's survival.
Reference:
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
